ScholarX: SOHN, CHONG IL

Detailed Information

SOHN, CHONG IL (손정일)

Medicine (Medicine)

Research Area

Tel 02-2001-8330
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

colorectal neoplasia:7||Advanced colorectal neoplasia:6||Colorectal neoplasia:6||obesity:6||Colonoscopy:6||Recurrence:5||Obesity:5||Fecal immunochemical test:5||Irritable bowel syndrome:5||Cohort studies:4||Gastroesophageal reflux:4||waist circumference:4||Helicobacter pylori:4||Inflammatory bowel diseases:3||Manometry:3||Disease progression:3||Young:3||colonoscopy:3||Colorectal neoplasms:3||probiotics:3||advanced colorectal neoplasia:3||Adenoma:3||Colorectal adenoma:3||fecal immunochemical test:3||Colorectal cancer:3||Upper esophageal sphincter:3||Crohn disease:3||insulin resistance:3||irritable bowel syndrome:3||Surveillance:3||Risk factors:3||Gastroscopy:2||Glucose metabolism:2||Chronic hepatitis B:2||cotinine:2||abdominal obesity:2||AsiaPacific Colorectal Screening:2||Dyslipidemia:2||Dyspepsia:2||Early detection of cancer:2||screening:2||body mass index:2||Endoscopic mucosal resection:2||Endoscopy:2||smoking:2||Immunization:2||Immunosuppression:2||Inflammatory bowel disease:2||Potassiumcompetitive acid blocker:2||Abdominal Distension:2||ulcerative:2||Entecavir:2||Colorectal neoplasm:2||colorectal cancer:2||Nonalcoholic fatty liver disease:2||Pyriform sinus:2||Cirrhosis:2||Liver cirrhosis:2||eradication:2||Esophagitis:2||esophagitis:2||Adefovir:2||Risk Factors:2||Risk assessment:2||family history of colorectal cancer:2||Rome III criteria:2||Colitis:2||Fatigue:2||Metabolic abnormalities:2||BMI:2||Stomach neoplasms:2||Deglutition:2||Stroke:2||Surveillance Colonoscopy Interval:2||Metachronous Advanced Colorectal Neoplasia:2||metachronous colorectal neoplasia:2||Colon Cancer:2||Gastric cancer:2||Transition Zone:2||Colonic Dilatation:2||Colonic Pseudoobstruction:2||Vaccine:2||Visceral:2||nonalcoholic fatty liver disease:2||nonalcoholic fatty liver disease:2||KIT gene:1||Lymphatic metastasis:1||MELDsodium:1||Mast cell, Permeability:1||Mebeverine:1||Men:1||Menarche:1||Metabolic Abnormality:1||Metabolic abnormality:1||Metabolic factors:1||Metabolic syndrome:1||Metachronous advanced colorectal neoplasia:1||Methylation:1||Methylation specific PCR:1||Microsatellite instability:1||Mosapride:1||Mosapride citrate:1||Multidetector row CT:1||Mural nodules:1||Natural killer cell:1||Natural killer cell activity:1||Nonalcoholic fatty liver disease:1||Obesity, metabolically benign:1||Octylonium:1||PAR2:1||PDGFRA gene:1||PETCT:1||PKCθ:1||Pegylated interferon:1||Permeability:1||Phase III clinical trial:1||Physical activity:1||Polyp detection rate:1||Polypectomy:1||Polyps:1||Potassiumcompetitive acid blockers:1||Prognosis:1||Proton Pumps:1||Proton pump inhibitor:1||Proximal:1||Quality of life:1||Ramosetron:1||Rapid onsite evaluation:1||Remission:1||Reproductive history:1||Risk stratification:1||Saccharomyces boulardii:1||Sarcopenia:1||Screening:1||Sensitivity:1||Silymarin:1||Small intestinal bacterial overgrowth:1||Smoking:1||Standardized uptake value:1||Stool DNA:1||Tegoprazan:1||Therapy:1||Time factors:1||Tiropramide:1||Tobacco:1||Tryptase:1||Ultrasonography:1||Visible tissue core:1||Waist circumference:1||Weight change:1||Young adults:1||Young population:1||Youngadult:1||adenoma:1||adiponectin:1||age:1||antiviral naive:1||balloonoccluded retrograde transvenous obliteration:1||basket cytology:1||bile duct obstruction:1||bile duct stricture:1||brush cytology:1||cecal intubation time:1||cholangiocarcinoma:1||cholelithiasis:1||chromogenic in situ hybridization:1||chronic:1||clevudine:1||cohort studies:1||colonic neoplasms:1||colorectal adenoma:1||colorectal adenomatous polyp:1||colorectal neoplasms:1||dynamic compliance:1||endoscopic Nbutyl2cyanoacrylate injection:1||endoscopic injection therapy:1||endoscopic retrograde cholangiography:1||entecavir:1||erosive esophagitis:1||extrahepatic cholangiocarcinoma:1||false negative:1||false positive:1||falsepositive:1||family history:1||fatty liver, leptin:1||fibrosis:1||firstdegree relative:1||gallbladder cancer:1||gallbladder polyps:1||gastric varices:1||gastroesophageal reflux:1||gastroesophageal reflux disease:1||genotypic resistance:1||hepatic encephalopathy:1||hepatitis B:1||immunohistochemistry:1||magnetic resonance cholangiography:1||metabolic abnormalities:1||metabolic syndrome:1||microalbuminuria:1||model for end stage liver disease (MELD):1||mosapride:1||mucoprotective agent:1||multidetector computed tomography cholangiography:1||multiplanar reformation:1||myopathy:1||natural killer cell activity:1||neu:1||non ulcer dyspepsia:1||oral glucose tolerance test:1||overweight:1||pain:1||passive smoking:1||peptic:1||peptic ulcer bleeding:1||portal hypertension:1||prediabetes:1||prevalence:1||prophylactic cholecystectomy:1||proton pump inhibitor:1||quantitative fecal immunochemical test:1||rebleeding:1||reflux symptoms:1||resistin:1||risk factors:1||sarcopenia:1||serrated polyp:1||sigmoidoscopy:1||skeletal muscle mass:1||smoking status:1||sodium hyaluronate:1||static compliance:1||steatosis:1||surveillance:1||type 2 diabetes:1||upper gastrointestinal endoscopy:1||variceal bleeding:1||young adults:1||대장내시경:1||대장의 신생물:1||선종:1||5HT 3 receptor antagonist:1||암의 조기진단:1||Accuracy:1||Adenoma detecti:1||Adenosine:1||Advanced Colorectal Neoplasm Risk Factors:1||Advanced colorectal neoplasm:1||Age:1||Alcohol Consumption:1||Anemia:1||Antiplatelet agent:1||Antispasmodic:1||Antiviral treatment:1||Anxiety:1||Aspirin:1||Atrophic gastritis:1||Biliary tract in:1||Bleeding:1||Branch duct intraductal papillary mucinous neoplasm:1||CA 199:1||CEA:1||CRC:1||CVD:1||Cancer:1||Cancerous change:1||Carbon tetrachloride:1||Caveolin1:1||ChildTurcottePugh:1||Cholangiocarcinoma:1||Cholesterol:1||Chronic hepatitis C:1||Cigarette:1||Clopidogrel:1||Colitis, ulcerative:1||Colon:1||Colon polypectomy:1||Colonoscopes:1||Colorectal Neoplasm:1||Colorectal distension:1||Computed tomography:1||Cost:1||Cotinine:1||Cyst wall thickening:1||DA9701 (Motilitone):1||DOG1:1||Deglutition disorders:1||Depression:1||Diabetes:1||Diabetes mellitus:1||Disinfectants:1||Distal:1||Duodenoscopy:1||EUSFNAB:1||Endoscopes:1||Endothelial nitric oxide synthase:1||Endotoxemia:1||Epidemiology:1||Eradication:1||Erosive esophagitis:1||Esophagitis, peptic:1||Extendedspectrum betalactamase:1||Extragastrointestinal stromal tumors:1||Family history:1||Fexuprazan:1||Gallbladder:1||Gallbladder cancer:1||Gastric Neoplasm:1||Gastritis:1||Gastroesophageal reflux disease:1||Gastrointestinal disease:1||HCV infection:1||HER2:1||HER2/neu:1||HOMAIR:1||Heart:1||Hemorrhoids:1||Hepatitis B:1||Hepatitis C:1||Homeostasis model assessment:1||Hyperalgesia:1||Hypopharynx:1||Insulin resistance:1||Intestinal permeability:1||Intestine:1||Iron deficiency anemia:1||Irondeficiency anemia:1||

STATISTICS: Total View:; Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE